Nano-Oncologicals - Pasta blanda

Libro en la base de datos desde 2017-05-10T22:54:35+02:00 (Madrid)
Página de detalles modificada por última vez el 2022-08-24T12:29:53+02:00 (Madrid)
ISBN/EAN: 3319344854

ISBN - escritura alterna:
3-319-34485-4, 978-3-319-34485-0
Mode alterno de escritura y términos de búsqueda relacionados:
Autor del libro: fuente, fuentes, jose maría alonso garcia, josé garcía

Datos del la editorial

Autor: Maria José Alonso; Marcos Garcia-Fuentes
Título: Advances in Delivery Science and Technology; Nano-Oncologicals - New Targeting and Delivery Approaches
Editorial: Springer; Springer International Publishing
473 Páginas
Año de publicación: 2016-09-10
Cham; CH
Impreso en
Idioma: Inglés
160,49 € (DE)
164,99 € (AT)
177,00 CHF (CH)
POD
XIV, 473 p. 58 illus., 51 illus. in color.

BC; Hardcover, Softcover / Biologie/Biochemie, Biophysik; Medizinische Chemie, Pharmazeutische Chemie; Verstehen; EPR; RNA delivery; biomarkers; liposomes; nanoparticles; Pharmaceutics; BB

This authoritative volume focuses on emerging technologies in cancer nano medicine, characterized by their multi-functionality and potential to address simultaneously diverse issues of clinical relevance in the treatment of cancer. The book consists of sixteen chapters divided into six sections: 1) Biological Barriers in Cancer; 2) Tumor Targeting; 3) Targeting the Immune System; 4) Gene Therapy; 5) Nano theranostics and 6) Translational Aspects of Nano-Oncologicals. The volume starts with an introduction describing the biological barriers associated with cancer therapy and highlighting ways to overcome such barriers through the use of nanotechnology. This is followed by an analysis of the two major targeting strategies currently under investigation in cancer therapy: namely, the targeting of cancer cells and the targeting of the immune system. In the first case, the book presents liposomal and polymer-based therapies, including photodynamic approaches. In the second case, it analyzes in detail the possibility of either improving the efficiency of the immune system toward preventing cancer progression (cancer immunomodulation) or generating responses against specific cancer antigens (cancer vaccines).

1 Passive vs active targeting: an update of the EPR role in drug delivery to tumors.- 2 The “EX” and the “SOMA”: How they communicate.- 3 Polymeric nano carriers for cancer therapy .- 4 Targeted Liposomes and Micelles as Carriers for Cancer Therapy.- 5 Photodynamic therapy for cancer: principles, clinical applications and nano technological approaches.- 6 Cancer Vaccines: fundamentals and strategies.- 7 Cancer immune modulation and immunosuppressive cells: current and future therapeutic approaches.- 8 Nanotechnology and cáncer immunomodulation.- 9 RNAi-based Nano-Oncologicals – Delivery and Clinical Applications.- 10 Nano-Platforms for Tumor-Targeted Delivery of Nucleic Acid Therapies.- 11 Multifunctional Gold Nano carriers for Cancer Theranostics – From bench to bedside and back again?.- 12 Micro bubbles as Theranostics Agents.- 13 Multimodal Nano-Systems for Cancer Diagnosis, Imaging and Therapy.- 14 Nano toxicology: Towards Safety-by-Design.- 15 Regulatory aspects of oncologicals: nano systems main challenges.- 16 BO-110, a dsRNA-based anticancer treatment.

is Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC) in Spain. She has made critical contributions to the design of novel nanostructures for the targeted delivery of drugs and vaccines and to the understanding of the interaction of nanoparticles with biological barriers. She is part of the scientific boards of a number of societies and the executive board of the Controlled Release Society. She is also a member of the editorial board of eight prestigious journals in the field of drug delivery.

is an Associate Professor of Pharmacy at Spain’s University of Santiago de Compostela (USC), where he also obtained his Ph.D. He was a visiting scholar at Purdue University in Indiana, USA and a Marie Curie postdoctoral scientist at ETH Zurich in Switzerland. He was recognized with a competitive contract from the regional government for the reintegration of excellent researchers. Marcos has work in the design of biomaterials and nanostructures for medical applications. His current focus is on nanomedicines and biomaterials for modulating progenitor cells and cancer stem cells.

This authoritative volume focuses on emerging technologies in cancer nanomedicine, characterized by their multi-functionality and potential to address simultaneously diverse issues of clinical relevance in the treatment of cancer. The book consists of sixteen chapters divided into six sections: 1) Biological Barriers in Cancer; 2) Tumor Targeting; 3) Targeting the Immune System; 4) Gene Therapy; 5) Nanotheranostics; and 6) Translational Aspects of Nano-Oncologicals. The volume starts with an introduction describing the biological barriers associated with cancer therapy and highlighting ways to overcome such barriers through the use of nanotechnology. This is followed by an analysis of the two major targeting strategies currently under investigation in cancer therapy: namely, the targeting of cancer cells and the targeting of the immune system. In the first case, the book presents liposomal and polymer-based therapies, including photodynamic approaches. In the second case, it analyzes in detail the possibility of either improving the efficiency of the immune system toward preventing cancer progression (cancer immunomodulation) or generating responses against specific cancer antigens (cancer vaccines).